On LinkedIn, he has called the firm, which markets GLP-1s and other pharmaceuticals, the fastest growing company in history, a phrase he has since removed from his profile
( 10.1172/JCI15595) [DOI] [PMC free article] [PubMed] [Google Scholar] 39.Baggio LL, Ussher JR, McLean BA, Cao X, Kabir MG, Mulvihill EE, Mighiu AS, Zhang H, Ludwig A, Seeley RJet al
Go deeper: Why do protein and digestive support matter on GLP-1s
Appetite suppression requires higher receptor occupancy than these doses provide
, derived from measured hemoglobin + hematocrit, is practical to calculate from a single blood draw and trend over time
Appetite suppression is often strongest in the first part of the day, and many patients tell me they're simply not hungry which creates a real risk of under-eating protein and starting the day in a deficit they don't recover from by dinner